Literature DB >> 1520053

Epidemiology of bacterial endocarditis in The Netherlands. II. Antecedent procedures and use of prophylaxis.

J T van der Meer1, J Thompson, H A Valkenburg, M F Michel.   

Abstract

BACKGROUND: The reported frequency with which endocarditis is ascribed to an antecedent dental or medical procedure varies from 3% to 62%.
METHODS: We performed a nationwide prospective study of the epidemiology of bacterial endocarditis in the Netherlands. During a 2-year period, all consecutively hospitalized patients suspected of having endocarditis were visited while still hospitalized for a review of the medical record and an in-person interview that focused on antecedent procedures and administered prophylaxis. All information was checked with pharmacists and dental and medical practitioners.
RESULTS: Of 427 patients with late prosthetic or native valve endocarditis, 275 were eligible for antibiotic prophylaxis because of a previously known cardiac lesion (n = 197) or a prosthetic valve (n = 78). Of these 275 patients, 64 (23.3%) had undergone a procedure with an indication for prophylaxis within 180 days of onset; in 31 (11.3%) the procedures had been within 30 days of onset. Antibiotic prophylaxis had been administered to 17 (26.6%) of the 64 patients and to eight (25.8%) of the 31 patients.
CONCLUSION: The results indicate that medical and dental procedures cause only a small fraction of endocarditis. The majority of patients develop the disease along other routes. For an incubation period of 180 days, full compliance with prophylaxis might have prevented endocarditis in 47 (17.1%) of 275 patients with late prosthetic or native valve endocarditis involving a previously known cardiac lesion who underwent a procedure with an indication for prophylaxis. For an incubation period of 30 days, prophylaxis might have prevented endocarditis in 23 (8.4%) of these 275 patients, or 5.3% of all patients with endocarditis (n = 427).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520053     DOI: 10.1001/archinte.152.9.1869

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  29 in total

Review 1.  [Infective endocarditis as cardiovascular emergency].

Authors:  B Plicht; R-A Jánosi; T Buck; R Erbel
Journal:  Internist (Berl)       Date:  2010-08       Impact factor: 0.743

2.  Infective endocarditis: rationale for revised guidelines for antibiotic prophylaxis.

Authors:  Prabhakaran P Gopalakrishnan; Sanjay K Shukla; Tahir Tak
Journal:  Clin Med Res       Date:  2009-07-16

Review 3.  Controversies in perioperative medicine.

Authors:  H Q Cheng
Journal:  West J Med       Date:  1998-12

4.  Antibiotic prophylaxis of endocarditis: the rest of the world and NICE.

Authors:  John B Chambers; David Shanson; Roger Hall; John Pepper; Graham Venn; Mark McGurk
Journal:  J R Soc Med       Date:  2011-04       Impact factor: 5.344

5.  Wait, not so fast. Are the new American Heart Association endocarditis prophylaxis guidelines safe, and where is the proof?

Authors:  Roland G Beaulieu
Journal:  Paediatr Child Health       Date:  2009-03       Impact factor: 2.253

Review 6.  Indications of antibiotic prophylaxis in dental practice- review.

Authors:  C Ramu; T V Padmanabhan
Journal:  Asian Pac J Trop Biomed       Date:  2012-09

7.  Incidence and sources of native and prosthetic joint infection: a community based prospective survey.

Authors:  C J Kaandorp; H J Dinant; M A van de Laar; H J Moens; A P Prins; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1997-08       Impact factor: 19.103

8.  Computer-assisted flapless implant placement reduces the incidence of surgery-related bacteremia.

Authors:  Volkan Arısan; Nilüfer Bölükbaşı; Lütfiye Öksüz
Journal:  Clin Oral Investig       Date:  2012-12-06       Impact factor: 3.573

9.  [Antimicrobial prophylaxis to prevent endocarditis: what has changed?].

Authors:  Dieter Horstkotte; Cornelia Piper
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

10.  Haemophilus aphrophilus endocarditis after tongue piercing.

Authors:  Hossein Akhondi; Ali R Rahimi
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.